The global sacroiliac joint fusion market is surging – from USD 721.2 million in 2023, it's projected to reach USD 2.49 billion by 2030, growing at a robust 19.8% CAGR. On the surgical side, the SI fusion procedures segment was valued at USD 293.8 million in 2023, expected to nearly triple to USD 984.9 million by 2030 (19.3% CAGR)

Key Growth Drivers

• Rising Burden of Low Back Pain: With over 1.7 billion people impacted globally, SI joint dysfunction accounts for approximately 15–30% of these cases

• Rapid Adoption of Minimally Invasive (MIS) Techniques: Markets are moving from open procedures to MIS, driven by improved outcomes, faster recovery, and higher patient comfort.

• Innovation in Implant Technology: Companies are investing in novel materials – like 3D-printed titanium Siros lateral implants – to enhance stability and fusion success.

• Improved Reimbursement Policies: Broader insurance coverage and Medicaid/BCBS inclusion have significantly boosted procedure uptake.

Regional & Clinical Momentum

• North America leads, holding over 40% of the market, thanks to infrastructure, proactive reimbursement, and innovation.

• Asia-Pacific, notably China and India, are set to be the fastest-growing regions, with expanding healthcare access and rising volumes of lower back pain cases.

• Ambulatory Surgical Centers (ASCs) are riding this wave, with the ASC SI fusion market poised to grow from USD 76 million to USD 257 million by 2030 (~19.4% CAGR)

Why This Industry is Heating Up

1. Clinical Shift – Surgeons are increasingly prioritizing MIS SI fusion to reduce patient recovery time and improve outcomes.

2. Tech Race – 3D-printed implants, advanced biomaterials, and surgical navigation are enhancing implant success and surgeon adoption.

3. Investor Interest – Accelerating clinical traction and predictable revenue models are attracting capital into MedTech, from VC to PE.

4. Diversified Applications – With indications spanning degenerative sacroiliitis to trauma and injections/RF ablation, market reach is broadening.

Final Takeaway

The SI joint fusion market is entering a high-growth phase underpinned by clinical need, innovation, and healthcare system support. With expansion across surgery, injections, and ambulatory care, it's not just a market – it's a movement transforming back pain treatment and drawing attention from clinicians and investors alike.

Let me know if you'd like a deeper dive into specific segments like implant innovation, regional forecasts, or the ASC-driven transformation.

Source: https://www.grandviewresearch.com/industry-analysis/sacroiliac-joint-fusion-market-report